EC50

Understanding EC50

EC50 represents the midpoint of a dose-response curve:

Response (%)
100 |           ___________
    |          /
 75 |         /
    |        /
 50 |-------*-------- EC50 point
    |      /
 25 |     /
    |    /
  0 |___/_____________________
       [Drug concentration]

Key Points

• Lower EC50 = Higher potency (less drug needed)
• Measured in concentration units (nM, uM, ng/mL)
• Specific to the measured effect (different endpoints may have different EC50s)
• Independent of maximum effect (a drug can be potent but have low efficacy)

EC50 vs Related Measures

Measure	Definition	Use Case
EC50	Concentration for 50% effect	Potency comparison
IC50	Concentration for 50% inhibition	Inhibitor potency
ED50	Dose effective in 50% of subjects	Clinical dosing
Kd	Dissociation constant	Binding affinity
Ki	Inhibition constant	Enzyme inhibition

EC50 vs Kd

• Kd measures binding affinity (how tightly drug binds)
• EC50 measures functional response (what happens after binding)
• They correlate but aren’t identical (receptor reserve, signal amplification)

Interpreting EC50 Values

Comparing Drug Potency

Drug	EC50	Relative Potency
Drug A	0.1 nM	Reference (1x)
Drug B	1 nM	10x less potent
Drug C	10 nM	100x less potent

What Affects EC50?

Factor	Effect on EC50
Higher receptor affinity	Lower EC50 (more potent)
Receptor reserve	Lower apparent EC50
Competing ligands	Higher apparent EC50
Assay conditions	Variable
Species/tissue type	Variable

EC50 in Peptide Research

GLP-1 Receptor Agonists

Relative potency at GLP-1 receptor (approximate):

Agonist	EC50 Range	Notes
Native GLP-1	~0.5 nM	Reference, short half-life
Semaglutide	~0.1-0.5 nM	Similar potency, much longer action
Tirzepatide	~0.1-1 nM	GLP-1 activity (also activates GIP)
Exenatide	~0.5-2 nM	Slightly less potent

Growth Hormone Secretagogues

Secretagogue	EC50 at GHS-R	Notes
Ghrelin	~1-5 nM	Endogenous ligand
Ipamorelin	~1-10 nM	Selective GHS-R agonist
GHRP-6	~1-5 nM	Less selective

Clinical Relevance

From EC50 to Dosing

EC50 helps determine clinical doses but doesn’t directly translate:

Laboratory EC50 → Animal studies → Human PK/PD → Clinical dose
        ↓
    Starting point for dose finding

Why EC50 Matters

1. Drug comparison: Rank candidates by potency
2. Dose prediction: Estimate therapeutic concentrations
3. Safety margins: Compare EC50 for efficacy vs toxicity
4. Receptor selectivity: Compare EC50 at different targets

Frequently Asked Questions

Does a lower EC50 mean a better drug?

Not necessarily. Lower EC50 means higher potency (less drug needed), but other factors matter: efficacy (maximum effect), selectivity (off-target effects), pharmacokinetics (how long it lasts), and safety profile. A less potent drug at adequate dose can be equally effective.

Why might EC50 values differ between studies?

EC50 depends on assay conditions: cell type, receptor expression level, incubation time, temperature, and measurement method. Published values should be compared cautiously when methodologies differ.

How does EC50 relate to the dose I take?

EC50 is a laboratory measurement of concentration needed for effect. Your dose must achieve adequate tissue concentrations, accounting for absorption, distribution, and metabolism. A drug with 1 nM EC50 doesn’t mean you take 1 nanomolar - the dose ensures target tissue reaches that concentration.